Limes Schlosskliniken AG
ISIN: DE000A0JDBC7
WKN: A0JDBC
16 July 2025 08:51AM

EQS-News: LIMES Schlossklinik Bergisches Land GmbH starts clinic operations

Limes Schlosskliniken AG · ISIN: DE000A0JDBC7 · EQS - Company News
Country: Germany · Primary market: Germany · EQS NID: 2170312

EQS-News: Limes Schlosskliniken AG / Key word(s): Expansion/Expansion
LIMES Schlossklinik Bergisches Land GmbH starts clinic operations

16.07.2025 / 08:51 CET/CEST
The issuer is solely responsible for the content of this announcement.


DGAP-Corporate News: LIMES Schlosskliniken AG:

 

LIMES Schlossklinik Bergisches Land GmbH starts clinic operations

 

Cologne, 16.07.2025. With today's award of the clinic licence, the LIMES Schlossklinik Bergisches Land will commence clinic operations. It will focus on the treatment of mental illnesses such as depression, trauma, anxiety and obsessive-compulsive disorders.

Embedded in 10 hectares of parkland in Lindlar, near Cologne, the new LIMES Schlossklinik Bergisches Land, with a capacity of 98 patient rooms and 130 beds on 9,400 square metres, is one of the most modern and exclusive private clinics for mental health in Europe.

The Healing Environment approach was given high priority in the clinic concept. The colour scheme and furnishings of the clinic create the best conditions for a positive recovery process. All rooms have a view of the clinic park.

A total of over 50 million euros was invested in the clinic site. LIMES Schlossklinik Bergisches Land has leased the property on a long-term basis. 22 million people live within a 200 km radius of the new clinic location.

More information at www.limes-schlossklinik-bergisches-land.de

 

 

Brief profile: The LIMES Schlosskliniken Group operates high-quality private clinics for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to subsidies and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de.

Your contact person:
LIMES Schlosskliniken AG, Petra Kaes, Investor Relations
Kaiser-Wilhelm-Ring 26, 50672 Cologne
Tel.: 0221 669 615 10, p.kaes@limes.care, www.limes-schlosskliniken.de

Language:  German
Company: LIMES Schlosskliniken AG, Kaiser-Wilhelm-Ring 26, 50672 Cologne, Germany
Phone:   49 221 669 615 10
Mail:  p.kaes@limes.care
Internet:  www.limes-schlosskliniken.de
ISIN:  DE000A0JDBC7
WKN:  AOJDBC
Stock exchange: Düsseldorf Open Market, Primary Market, XETRA

End of the message

 



16.07.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Limes Schlosskliniken AG
Kaiser-Wilhelm-Ring 26
50672 Köln
Germany
ISIN: DE000A0JDBC7
WKN: A0JDBC
Listed: Regulated Unofficial Market in Dusseldorf
EQS News ID: 2170312

 
End of News EQS News Service

2170312  16.07.2025 CET/CEST

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2019 2020 2021 2022 2023 2024 2025e
Sales1 8,18 11,02 23,44 28,81 37,17 37,45 50,00
EBITDA1,2 0,26 0,84 6,02 8,65 7,67 7,05 8,70
EBITDA-Margin3 3,18 7,62 25,68 30,02 20,64 18,83 17,40
EBIT1,4 -0,54 -0,43 4,53 6,00 5,03 4,29 5,75
EBIT-Margin5 -6,60 -3,90 19,33 20,83 13,53 11,46 11,50
Net Profit (Loss)1 -0,83 -0,69 4,11 4,86 3,91 3,23 3,90
Net-Margin6 -10,15 -6,26 17,53 16,87 10,52 8,63 7,80
Cashflow1,7 0,17 0,76 4,77 8,04 6,29 7,46 6,85
Earnings per share8 -2,81 -2,37 13,45 14,34 11,58 10,61 13,30
Dividend per share8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: B-S-H Collegen

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Limes Schlosskliniken
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
A0JDBC DE000A0JDBC7 AG 97,13 Mio € 12.10.2018 Kaufen 9F28WWVR+CQ
* * *
PE 2026e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
20,38 23,59 0,86 61,94 4,12 13,01 2,59
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
0,00 0,00 0,00 0,00%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
06.06.2025 01.09.2025 12.05.2025
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
+1,24%
326,00 €
ATH 408,00 €
-8,84% -3,80% -1,81% -1,21% +210,48%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL